![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Bristol-Myers Squibb Company will announce results for the first quarter of 2013 on Thursday April 25 2013. During a conference call at 10:30 a.m. EDT on April 25 company executives will review financial information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing 913-312-0650 confirmation code: 1234744. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. EDT on April 25 through midnight EDT on May 9 2013. The replay will also be available through http://investor.bms.com or by dialing 402-280-9013 confirmation code: 1234744.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover develop and deliver innovative medicines that help patients prevail over serious diseases.
